# Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

> clinical trial · VERIFIED · 2026-07-08

Status: COMPLETED · Sponsor: Nanjing Immunophage Biotech Co., Ltd · Condition: Safety Issues

- Company: Nanjing Immunophage Biotech Co., Ltd
- Sector: Safety Issues
- Primary source: https://clinicaltrials.gov/study/NCT05142592

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.